Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK

TN Flynn; SM Kelsey; DL Hazel; JF Guest

Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK

TN Flynn
, SM Kelsey
, DL Hazel
, JF Guest

Bristol Medical School (PHS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

29 Citations (Scopus)

Translated title of the contribution	Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK
Original language	English
Pages (from-to)	543 - 550
Number of pages	8
Journal	PharmacoEconomics
Volume	16 (5 Pt2)
Publication status	Published - Nov 1999

Bibliographical note

Publisher: Adis International

Access to Document

http://www.ingentaconnect.com/content/adis/pec/1999/00000016/00000005/art00010

Handle.net

Persistent link

Cite this

@article{0bd7c0a8b2bb497db7b208167575a094,

title = "Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK",

author = "TN Flynn and SM Kelsey and DL Hazel and JF Guest",

note = "Publisher: Adis International",

year = "1999",

month = nov,

language = "English",

volume = "16 (5 Pt2)",

pages = "543 -- 550",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis",

}

TY - JOUR

T1 - Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK

AU - Flynn, TN

AU - Kelsey, SM

AU - Hazel, DL

AU - Guest, JF

N1 - Publisher: Adis International

PY - 1999/11

Y1 - 1999/11

M3 - Article (Academic Journal)

SN - 1170-7690

VL - 16 (5 Pt2)

SP - 543

EP - 550

JO - PharmacoEconomics

JF - PharmacoEconomics

ER -